A Study by ChromaDex to Assess the Effects of TRU NIAGEN on Cognitive Function, Mood and Sleep in Older Adults

Sponsor: ChromaDex, Inc.
Collaborator: Midwest Center for Metabolic and Cardiovascular Research

Purpose

To investigate the effects of 300mg/day and 1000mg/day NR compared to a placebo control on cognitive function, mood and sleep in men and women over 55 years of age.

Study Design

Randomized, double-blind, placebo controlled cross-over study

Dose

300mg/day, 1000mg/day, or placebo

Length of Intervention

8 weeks per treatment (24 weeks total)

Intrinsic Capacity

Cognition

Status

Completed

Condition or Disease 

Cognitive Function
Mood
Sleep

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.

Clinical Studies, Cognition, CompletedANAD Staff